IL3RA and leukemia: Flow cytometry-based analysis of the BM and PB 28 days following CAR T cell infusion also showed a significantly higher number of residual leukemia cells in mice injected with CTLA-4positive anti-CD123 CAR T cells compared to the CTLA-4negative group (Fig. 7h).